We are live on ! Find out more
LVTX

LAVA Therapeutics
LVTX

Delisted

LVTX was delisted on the 20th of November, 2025.

Back to rankings

Fund managers haven’t disclosed any holdings of LVTX yet.

LVTX Hedge Fund Activity: Q4 2025 in Review

0 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in LAVA Therapeutics (LVTX) for Q4 2025, worth a combined $0 — down 100% from $16.1M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of LVTX and 0 opened new positions — a net loss of 21 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Shay Capital, exiting entirely with an estimated $3.98M sold.

  • 0 institutional investors held LAVA Therapeutics (LVTX) as of Q4 2025, down from 21 in Q3 2025.
  • Funds reported $0 of LAVA Therapeutics stock for Q4 2025, down 100% quarter-over-quarter.
  • 0 funds opened new LAVA Therapeutics positions in Q4 2025 and 21 closed out, a net change of -21 holders.
  • The largest LAVA Therapeutics seller in Q4 2025 was Shay Capital, an estimated $3.98M sold.

Based on aggregated 13F filings for Q4 2025.